bibliographicCitation |
Ferrer-Soler L, Vazquez-Martin A, Brunet J, Menendez J, De Llorens R, Colomer R. An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa™)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review). Int J Mol Med. 2007 Jul 01;(). doi: 10.3892/ijmm.20.1.3. |